PR-POSITIVE BREAST CANCER
Clinical trials for PR-POSITIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new PR-POSITIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for PR-POSITIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug tested for Tough-to-Treat cancers
Disease control TerminatedThis study tested an experimental drug called VLS-101 (zilovertamab vedotin) in 102 people with advanced solid tumors that had spread and stopped responding to previous treatments. The trial aimed to see if the drug could shrink tumors and was safe for cancers including breast, l…
Matched conditions: PR-POSITIVE BREAST CANCER
Phase: PHASE2 • Sponsor: VelosBio Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Early trial halted for advanced breast cancer treatment
Disease control TerminatedThis early-stage study aimed to find a safe dose for combining two drugs (infigratinib and tamoxifen) to treat advanced breast cancer with specific genetic changes. It enrolled only 4 participants before being terminated. The main goal was to identify side effects and determine i…
Matched conditions: PR-POSITIVE BREAST CANCER
Phase: PHASE1 • Sponsor: Jennifer Lee Caswell-Jin • Aim: Disease control
Last updated Feb 17, 2026 14:40 UTC